Abstract:Study question: Does a heterozygous mutation in AMHR2, identified in whole-exome sequencings (WES) of patients with primary ovarian insufficiency (POI), cause a defect in anti-Müllerian hormone (AMH) signaling? Summary answer: The I209N mutation at the adenosine triphosphate binding domain of AMHR2 exerts dominant negative defects in the AMH signaling pathway. What is known already: Previous studies have demonstrated the associations of several sequence variants in AMH or AMHR2 with POI, but no functional assay has been performed to verify whether there was any defect on AMH signaling. Study design, samples/materials, methods: Ninety-six unrelated female Chinese Han patients were diagnosed with idiopathic POI and subjected to WES. In silico analysis was done for the sequence variants followed by molecular assays to examine the functional effects of the sequence variants in human granulosa cells. In silico analysis, immunostaining, Western analysis, genome-wide expression analysis, quantitatively polymerase chain reaction were applied to the characterization of the sequence variants. Main results and the role of chance: We identified one novel heterozygous missense variant, p.Ala17Glu (A17E), in AMHR2. Subsequently, A17E and two independently reported missense variants, p.Ile209Asn (I209N) and p.Leu354Phe (L354F), were evaluated for effects on the AMH signaling pathway. In silico analysis predicted that all three variants may be deleterious. However, only one variant, I209N, showed severe defects in transducing the AMH signal as well as impaired SMAD1/5/8 phosphorylation. Furthermore, using genome-wide gene expression analysis, we identified genes whose expression was affected by the mutation, these included genes previously reported to participate in AMH signaling as well as newly identified genes. They are EMILIN2, FAM155A, GATA2, HES5, ID1, ID2, RLTPR, SMAD7, CBL, MALAT1 and SMARCA2. Large scale data: None. Limitations, reasons for caution: Although the in vitro assays demonstrated the causative effect of I209N on AMH signaling, further studies need to validate its long-term effects on folliculogenesis and POI. Wider implications of the findings: These results will aid both researchers and clinicians in understanding the molecular pathology of AMH signaling and POI to develop diagnostic assays or therapeutics approaches. Study funding and competing interests: Research funding is provided by the Ministry of Science and Technology of China [2012CB944704; 2012CB966702], and the National Natural Science Foundation of China [Grant number: 31171429]. The authors declare no conflict of interest.

A Homozygous NOBOX Truncating Variant Causes Defective Transcriptional Activation and Leads to Primary Ovarian Insufficiency.

Heterozygous Loss-of-function Variants in LHX8 Cause Female Infertility Characterized by Oocyte Maturation Arrest.

Whole‐exome Sequencing Identifies a Homozygous Donor Splice‐site Mutation in STAG3 That Causes Primary Ovarian Insufficiency

Homozygous Variants in PANX1 Cause Human Oocyte Death and Female Infertility.

Basonuclin 1 Deficiency is a Cause of Primary Ovarian Insufficiency.

Novel Inactivating Mutations in the FSH Receptor Cause Premature Ovarian Insufficiency with Resistant Ovary Syndrome

Identification and Characterization of Novel Compound Heterozygous Variants in FSHR Causing Primary Ovarian Insufficiency with Resistant Ovary Syndrome.

A Heterozygous Truncating Mutation in BNC1 Causes Male Subfertility: BNC1 Cooperates with TAF7L to Regulate Spermatogenesis

XRCC2 Mutation Causes Premature Ovarian Insufficiency As Well As Non‐obstructive Azoospermia in Humans

Haploinsufficiency in Non-Homologous End Joining Factor 1 Induces Ovarian Dysfunction in Humans and Mice.

WT1, NR0B1, NR5A1, LHX9, ZFP92, ZNF275, INSL3, and NRIP1 Genetic Variants in Patients with Premature Ovarian Insufficiency in a Mexican Cohort

Whole exome sequencing identified a rare <i>WT1</i> loss-of-function variant in a non-syndromic POI patient

Sequence Variants of Khdrbs1 As High Penetrance Susceptibility Risks for Primary Ovarian Insufficiency by Mis-Regulating Mrna Alternative Splicing

DMC1 Mutation That Causes Human Non-Obstructive Azoospermia and Premature Ovarian Insufficiency Identified by Whole-Exome Sequencing

Novel Loss-of-function Variants of ZP3 Associated with Premature Ovarian Insufficiency

A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Müllerian hormone signaling pathway

Landscape of pathogenic mutations in premature ovarian insufficiency

Novel LAT Pathogenic Variants in a POI Family and Its Role in the Ovary

Bi-allelic SPATA22 variants cause premature ovarian insufficiency and nonobstructive azoospermia due to meiotic arrest

A Novel Homozygous Mutation of Bone Morphogenetic Protein 15 Identified in a Consanguineous Marriage Family with Primary Ovarian Insufficiency.

Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency